Patents by Inventor Qing Yu WENG

Qing Yu WENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of cancers having alterations within the SWI/SNF chromatin remodeling complex
    Patent number: 11433068
    Abstract: This disclosure provides compositions and methods of treating cancer by inhibiting histone methyltransferases alone or in combination by synergistically inhibiting a histone demethylase, or a histone deacetylase (HDAC), or a bromodomain (BRD)-containing protein, or a B-Raf kinase. In particular, the cancers have deficient of SWI/SNF chromatin remodeling complexes because of mutations in one or more of the complex's subunit members.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: September 6, 2022
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: David E. Fisher, Qing Yu Weng, Shinichiro Kato
  • TREATMENT OF CANCERS HAVING ALTERATIONS WITHIN THE SWI/SNF CHROMATIN REMODELING COMPLEX
    Publication number: 20190201396
    Abstract: This disclosure provides compositions and methods of treating cancer by inhibiting histone methyltransferases alone or in combination by synergistically inhibiting a histone demethylase, or a histone deacetylase (HDAC), or a bromodomain (BRD)-containing protein, or a B-Raf kinase. In particular, the cancers have deficient of SWUSNF chromatin remodeling complexes because of mutations in one or more of the complex's subunit members.
    Type: Application
    Filed: September 7, 2017
    Publication date: July 4, 2019
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: David E. FISHER, Qing Yu WENG, Shinichiro KATO